HQL ETF (abrdn Life Sciences Investors) is managed by abrdn Life Sciences Investors. sectors including Unknown.

HQL performance shows data across multiple time periods..

HQL top holdings include Regeneron Pharmaceuticals Inc (7.4%), Amgen Inc (7.3%), Gilead Sciences Inc (6.6%), Vertex Pharmaceuticals Inc (4.5%), Alnylam Pharmaceuticals Inc (3.5%). View all HQL holdings, sector breakdown, or dividend history.

HQL can be compared against other funds using the overlap calculator or side-by-side comparison tool. HQL alternatives are available via the screener, along with tax-loss harvesting opportunities.